FRONTEO [2158]: FRONTEO and Human Life Code launch project to elucidate the mechanism of action of cell therapy products, 12 November 2026 (timely disclosure): Nikkei Company Information DIGITAL

The story

FRONTEO and Human Life Code have launched a joint project aimed at elucidating the mechanism of action of cell therapy products.

The project is being undertaken with the intention of deepening the companies’ understanding of the cell therapy field and strengthening the foundation for future research and development.

The announcement was made at 16:00 on 12 November 2026 and disclosed through the timely disclosure bulletin and Nikkei Company Information DIGITAL.

At a glance

CompanyFRONTEO and Human Life Code launch a joint project

ContentResearch project aimed at elucidating the mechanism of action of cell therapy products

DateAnnounced at 16:00 on 12 November 2026

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

The NikkeiNews

AgreesOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.